+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Immunoassay Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904903
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoassay market stands at the intersection of diagnostics, biotechnology, and modern healthcare requirements. Industry leaders are drawn to this sector, which rewards operational flexibility and continuous innovation. As market complexity deepens, robust regulatory frameworks enhance reliability and ensure high standards—making it essential for senior decision-makers to understand the nuances shaping this dynamic landscape.

Market Snapshot: Immunoassay Market Size and Growth

The immunoassay market expanded from USD 30.38 billion in 2025 to USD 32.61 billion in 2026. Projected to achieve a CAGR of 7.36%, the sector is forecast to reach USD 49.98 billion by 2032. Market growth is being propelled by the increasing prevalence of chronic and infectious diseases, broadening applications in diagnostics, and rising investment in both laboratory and point-of-care platforms. This momentum reflects strong demand for rapid, reliable results, especially as providers look to improve patient outcomes and minimize diagnostic turnaround times.

Scope & Segmentation of the Immunoassay Market

This report delivers a comprehensive analysis of the immunoassay sector, structured to support informed decisions. The market is diversified by advanced technologies, operational models, and regional specifics:

  • Types: Both qualitative and quantitative immunoassays are examined, highlighting their roles across diverse clinical and diagnostic scenarios.
  • Technologies: Includes enzyme immunoassays, enzyme-linked immunosorbent assays, fluorescent immunoassays, lateral flow tests, radioimmunoassays, alongside innovative microfluidics and biosensor solutions.
  • Instruments & Consumables: Focuses on analyzers, laboratory kits, biosensor equipment, microplates, PCR machines, and core reagents such as antibodies, enzymes, antigens, buffers, substrates, and standards.
  • Sample Types: Analyzes use of blood, tissue, saliva, and urine—driving utility for decentralized and noninvasive testing protocols.
  • Detection Modes: Reviews chemiluminescent, colorimetric, fluorometric, and radioisotopic detection, framed by workflow compatibility and sensitivity requirements.
  • Applications: Covers allergy, autoimmune and cardiovascular conditions, endocrinology, infectious disease, oncology, drug screening, and environmental toxicology.
  • End Users: Addresses diagnostic labs, hospitals, clinics, contract research organizations, pharmaceutical and biotech enterprises, plus research institutes.
  • Deployment Models: Compares centralized laboratory testing with point-of-care and remote diagnostics solutions to illustrate emerging trends.
  • Regions: Evaluates geographic patterns across the Americas, Europe/Middle East/Africa, and Asia-Pacific, reflecting infrastructure readiness, regulatory climates, and localized partnership strategies.

Key Takeaways for Senior Decision-Makers

  • Automation and modular assay systems are shaping new benchmarks in laboratory capacity and in distributed diagnostic models, accelerating efficiency across care settings.
  • The push toward personalized medicine is prompting a transition to biomarker-driven immunoassays and custom therapeutic monitoring, thereby expanding scope for targeted patient management.
  • Next-generation devices combine digital technologies, multiplex formats, and proprietary reagents for faster and more accurate results across testing environments.
  • Industry consolidation is underway as alliances, acquisitions, and cross-sector partnerships strengthen portfolios and optimize go-to-market timelines for advanced solutions.
  • Regulatory cohesion, particularly within the EU, is driving wider global harmonization but also imposes rigorous compliance, influencing market entry strategies for new stakeholders.
  • Procurement is increasingly influenced by sustainability targets and the geographic localization of manufacturing, supporting long-term cost containment and environmental alignment.

Tariff Impact on Immunoassay Supply Chains and Sourcing

The application of United States tariffs in 2025 has elevated costs for key imports including reagents, instruments, and clinical kits within the immunoassay market. In response, manufacturers are prioritizing domestic sourcing, adapting contractual terms to account for shifting tariff structures, and building new supply chain resilience measures. Additional investments in local production sites and closer collaboration with trade specialists are helping to fortify product availability and maintain competitive pricing, even as the operating landscape becomes more complex.

Methodology & Data Sources

Primary interviews with sector leaders, scientific experts, and supply chain specialists supported this analysis. Rigorous validation was conducted using secondary data from peer-reviewed publications, regulatory records, and market filings. Insights were reinforced using triangulation and external subject matter review to ensure accuracy.

Why This Report Matters

  • Delivers actionable insights into evolving market segmentation, technology pathways, and progressive end-user trends.
  • Assists in formulating responses to supply chain challenges and regulatory adaptation requirements facing the immunoassay market.
  • Supports executives in planning investments and strategic partnerships with substantiated, current market intelligence for expansion and operational efficiency.

Conclusion

Senior decision-makers equipped with this analysis can proactively manage risk and leverage opportunities as the immunoassay sector evolves. Success hinges on adaptability, focused innovation, and strict operational oversight within a changing regulatory and technological context.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immunoassay Market, by Type
8.1. Qualitative Immunoassays
8.2. Quantitative Immunoassays
9. Immunoassay Market, by Technology
9.1. Enzyme Immunoassays
9.2. Enzyme-Linked Immunosorbent Assay
9.3. Fluorescent Immunoassay
9.4. Lateral Flow Assay
9.5. Radioimmunoassay
9.6. Western Blot
10. Immunoassay Market, by Instruments
10.1. Analyzers & Kits
10.2. Biosensors
10.3. Microfluidic Devices
10.4. Microplates
10.5. PCR Devices
10.6. Reagents
10.6.1. Antibodies
10.6.2. Antigens
10.6.3. Blocking Reagents
10.6.4. Buffers & Standards
10.6.5. Enzymes
10.6.6. Substrates
10.7. Software & Services
11. Immunoassay Market, by Sample Types
11.1. Blood Samples
11.2. Saliva Samples
11.3. Tissue Samples
11.4. Urine Samples
12. Immunoassay Market, by Detection Modes
12.1. Chemiluminescent
12.2. Colorimetric
12.3. Fluorometric
12.4. Radioisotopic
13. Immunoassay Market, by Application Areas
13.1. Allergy
13.2. Autoimmune Diseases
13.3. Cardiology
13.4. Endocrinology
13.5. Infectious Diseases
13.6. Oncology
13.7. Toxicology
13.7.1. Drug Screening
13.7.2. Environmental Testing
14. Immunoassay Market, by End Users
14.1. Contract Research Organizations
14.2. Diagnostic Laboratories
14.3. Hospitals & Clinics
14.4. Pharmaceutical & Biotechnology Companies
14.5. Research Institutions
15. Immunoassay Market, by Deployment Types
15.1. Laboratory Tests
15.2. Point-of-care Test
16. Immunoassay Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Immunoassay Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Immunoassay Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Immunoassay Market
20. China Immunoassay Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Abbott Laboratories
21.6. Agilent Technologies Inc.
21.7. Almac Group Limited
21.8. ANP Technologies, Inc.
21.9. Autobio Diagnostics Co., Ltd.
21.10. Becton, Dickinson and Company
21.11. Bio-Rad Laboratories, Inc.
21.12. Bio-Techne Corporation
21.13. BioLegend, Inc.
21.14. bioMérieux S.A.
21.15. Biosurfit SA
21.16. Boditech Med Inc.
21.17. Charles River Laboratories International, Inc.
21.18. Danaher Corporation
21.19. Diasorin S.p.A.
21.20. Dynex Technologies, Inc.
21.21. Epitope Diagnostics Inc.
21.22. F. Hoffmann-La Roche Ltd.
21.23. Fapon Biotech Inc.
21.24. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
21.25. H.U. Group Holdings Inc.
21.26. J. Mitra & Co. Pvt. Ltd.
21.27. Kamiya Biomedical Company
21.28. Koninklijke Philips N.V.
21.29. Merck KGaA
21.30. MiCo BioMed, Inc.
21.31. NanoEntek
21.32. Nanomix, Inc.
21.33. OPKO Health, Inc.
21.34. Promega Corporation
21.35. QIAGEN N.V.
21.36. Quanterix Corporation
21.37. QuidelOrtho Corporation
21.38. Randox Laboratories Ltd.
21.39. Revvity, Inc. (Formarly PerkinElmer, Inc.)
21.40. Sekisui Diagnostics, LLC
21.41. Shenzhen Micropoint Biotechnologies Co., Ltd.
21.42. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
21.43. Siemens Healthineers AG
21.44. Sysmex Corporation
21.45. Tecan Trading AG
21.46. Thermo Fisher Scientific Inc.
21.47. Tosoh Corporation
21.48. WAK-Chemie Medical GmbH
21.49. Zoetis Inc.
21.50. Zybio Inc.
List of Figures
FIGURE 1. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUALITATIVE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY QUANTITATIVE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOIMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY WESTERN BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANALYZERS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOASSAY MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROFLUIDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNOASSAY MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAY MARKET SIZE, BY PCR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNOASSAY MARKET SIZE, BY ANTIGENS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOCKING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMMUNOASSAY MARKET SIZE, BY BUFFERS & STANDARDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNOASSAY MARKET SIZE, BY SUBSTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNOASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOASSAY MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMMUNOASSAY MARKET SIZE, BY SALIVA SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNOASSAY MARKET SIZE, BY TISSUE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNOASSAY MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IMMUNOASSAY MARKET SIZE, BY CHEMILUMINESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNOASSAY MARKET SIZE, BY COLORIMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNOASSAY MARKET SIZE, BY FLUOROMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNOASSAY MARKET SIZE, BY RADIOISOTOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IMMUNOASSAY MARKET SIZE, BY ALLERGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IMMUNOASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IMMUNOASSAY MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL IMMUNOASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL IMMUNOASSAY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL IMMUNOASSAY MARKET SIZE, BY DRUG SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL IMMUNOASSAY MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL IMMUNOASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL IMMUNOASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL IMMUNOASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL IMMUNOASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL IMMUNOASSAY MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL IMMUNOASSAY MARKET SIZE, BY LABORATORY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL IMMUNOASSAY MARKET SIZE, BY POINT-OF-CARE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS IMMUNOASSAY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 192. EUROPE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 194. EUROPE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 198. EUROPE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 199. EUROPE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 200. EUROPE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 201. EUROPE IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 202. EUROPE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 214. AFRICA IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 216. AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 217. AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 218. AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 219. AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 220. AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 221. AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 223. AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 237. ASEAN IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. ASEAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 239. ASEAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. ASEAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 241. ASEAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 242. ASEAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 243. ASEAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 244. ASEAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 245. ASEAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 246. ASEAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 247. ASEAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 248. GCC IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. GCC IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 250. GCC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. GCC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 252. GCC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 253. GCC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 254. GCC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 255. GCC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 256. GCC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 257. GCC IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 258. GCC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 270. BRICS IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. BRICS IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 272. BRICS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. BRICS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 274. BRICS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 275. BRICS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 276. BRICS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 277. BRICS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 278. BRICS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 279. BRICS IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 280. BRICS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 281. G7 IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. G7 IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 283. G7 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. G7 IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 285. G7 IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 286. G7 IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 287. G7 IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 288. G7 IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 289. G7 IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 290. G7 IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 291. G7 IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 292. NATO IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. NATO IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 294. NATO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 295. NATO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 296. NATO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 297. NATO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 298. NATO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 299. NATO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 300. NATO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 301. NATO IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 302. NATO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)
TABLE 315. CHINA IMMUNOASSAY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 316. CHINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 317. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 318. CHINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 319. CHINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 320. CHINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2018-2032 (USD MILLION)
TABLE 321. CHINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2018-2032 (USD MILLION)
TABLE 322. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
TABLE 323. CHINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2018-2032 (USD MILLION)
TABLE 324. CHINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
TABLE 325. CHINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Immunoassay market report include:
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Almac Group Limited
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Koninklijke Philips N.V.
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc. (Formarly PerkinElmer, Inc.)
  • Sekisui Diagnostics, LLC
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Table Information